Global Nuclear Medicine Diagnostic Equipment Market Growth 2026-2032
The global Nuclear Medicine Diagnostic Equipment market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Nuclear medicine diagnosis mainly refers to nuclide imaging diagnosis, which can be divided into single photon emission computed tomography (SPECT) and positron emission computed tomography (PET) according to the different ways and types of radioactive elements used to emit gamma photons. Its principle is to inject single-photon/positron radioactive drugs into the human body, and then use SPECT or PET equipment to image the distribution of radionuclides, so as to analyze the function or metabolism of various organs to diagnose diseases. .
In terms of the popularity and advancement of the product, SPECT was used clinically before PET, and the penetration rate is higher than that of PET, but the imaging effect of PET is clearer, the radiation damage to the human body is less, and it is more advanced than SPECT. In recent years, the development of PET The market is also growing faster. PET equipment is usually fused with CT and MRI to form PET/CT and PET/MR, and SPECT equipment is usually fused with CT to form SPECT/CT. Separate PET and SPECT equipment have gradually withdrawn from the market.
Currently commonly used medical imaging methods include X-ray imaging, ultrasound imaging, CT, nuclear magnetic resonance MRI, SPECT/CT, PET/CT and PET/MR.
LP Information, Inc. (LPI) ' newest research report, the “Nuclear Medicine Diagnostic Equipment Industry Forecast” looks at past sales and reviews total world Nuclear Medicine Diagnostic Equipment sales in 2025, providing a comprehensive analysis by region and market sector of projected Nuclear Medicine Diagnostic Equipment sales for 2026 through 2032. With Nuclear Medicine Diagnostic Equipment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nuclear Medicine Diagnostic Equipment industry.
This Insight Report provides a comprehensive analysis of the global Nuclear Medicine Diagnostic Equipment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nuclear Medicine Diagnostic Equipment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nuclear Medicine Diagnostic Equipment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nuclear Medicine Diagnostic Equipment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nuclear Medicine Diagnostic Equipment.
This report presents a comprehensive overview, market shares, and growth opportunities of Nuclear Medicine Diagnostic Equipment market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Nuclear medicine diagnosis mainly refers to nuclide imaging diagnosis, which can be divided into single photon emission computed tomography (SPECT) and positron emission computed tomography (PET) according to the different ways and types of radioactive elements used to emit gamma photons. Its principle is to inject single-photon/positron radioactive drugs into the human body, and then use SPECT or PET equipment to image the distribution of radionuclides, so as to analyze the function or metabolism of various organs to diagnose diseases. .
In terms of the popularity and advancement of the product, SPECT was used clinically before PET, and the penetration rate is higher than that of PET, but the imaging effect of PET is clearer, the radiation damage to the human body is less, and it is more advanced than SPECT. In recent years, the development of PET The market is also growing faster. PET equipment is usually fused with CT and MRI to form PET/CT and PET/MR, and SPECT equipment is usually fused with CT to form SPECT/CT. Separate PET and SPECT equipment have gradually withdrawn from the market.
Currently commonly used medical imaging methods include X-ray imaging, ultrasound imaging, CT, nuclear magnetic resonance MRI, SPECT/CT, PET/CT and PET/MR.
LP Information, Inc. (LPI) ' newest research report, the “Nuclear Medicine Diagnostic Equipment Industry Forecast” looks at past sales and reviews total world Nuclear Medicine Diagnostic Equipment sales in 2025, providing a comprehensive analysis by region and market sector of projected Nuclear Medicine Diagnostic Equipment sales for 2026 through 2032. With Nuclear Medicine Diagnostic Equipment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nuclear Medicine Diagnostic Equipment industry.
This Insight Report provides a comprehensive analysis of the global Nuclear Medicine Diagnostic Equipment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nuclear Medicine Diagnostic Equipment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nuclear Medicine Diagnostic Equipment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nuclear Medicine Diagnostic Equipment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nuclear Medicine Diagnostic Equipment.
This report presents a comprehensive overview, market shares, and growth opportunities of Nuclear Medicine Diagnostic Equipment market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- SPECT
- PET
- Tumor Imaging
- Bone Marrow Imaging
- Endocrine System Imaging
- Urinary System Imaging
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GE HealthCare
- Siemens Healthineers
- Philips
- Mediso Medical Imaging Systems
- Digirad
- Toshiba
- Compa??a Mexicana
- SurgicEye
- CMR Naviscan
- DDD-Diagnostic
- Positron
- TeraRecon
- Neusoft Group
- United Imaging
- MinFound Medical
- SinoUnion Healthcare
- Top Grade Healthcare
- What is the 10-year outlook for the global Nuclear Medicine Diagnostic Equipment market?
- What factors are driving Nuclear Medicine Diagnostic Equipment market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Nuclear Medicine Diagnostic Equipment market opportunities vary by end market size?
- How does Nuclear Medicine Diagnostic Equipment break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nuclear Medicine Diagnostic Equipment Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Nuclear Medicine Diagnostic Equipment by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Nuclear Medicine Diagnostic Equipment by Country/Region, 2021, 2025 & 2032
2.2 Nuclear Medicine Diagnostic Equipment Segment by Type
2.2.1 SPECT
2.2.2 PET
2.2.3 Nuclear Medicine Diagnostic Equipment Sales by Type
2.2.3.1 Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Type (2021-2026)
2.2.3.2 Global Nuclear Medicine Diagnostic Equipment Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Nuclear Medicine Diagnostic Equipment Sale Price by Type (2021-2026)
2.3 Nuclear Medicine Diagnostic Equipment Segment by Application
2.3.1 Tumor Imaging
2.3.2 Bone Marrow Imaging
2.3.3 Endocrine System Imaging
2.3.4 Urinary System Imaging
2.3.5 Others
2.3.6 Nuclear Medicine Diagnostic Equipment Sales by Application
2.3.6.1 Global Nuclear Medicine Diagnostic Equipment Sale Market Share by Application (2021-2026)
2.3.6.2 Global Nuclear Medicine Diagnostic Equipment Revenue and Market Share by Application (2021-2026)
2.3.6.3 Global Nuclear Medicine Diagnostic Equipment Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Nuclear Medicine Diagnostic Equipment Breakdown Data by Company
3.1.1 Global Nuclear Medicine Diagnostic Equipment Annual Sales by Company (2021-2026)
3.1.2 Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Company (2021-2026)
3.2 Global Nuclear Medicine Diagnostic Equipment Annual Revenue by Company (2021-2026)
3.2.1 Global Nuclear Medicine Diagnostic Equipment Revenue by Company (2021-2026)
3.2.2 Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Company (2021-2026)
3.3 Global Nuclear Medicine Diagnostic Equipment Sale Price by Company
3.4 Key Manufacturers Nuclear Medicine Diagnostic Equipment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nuclear Medicine Diagnostic Equipment Product Location Distribution
3.4.2 Players Nuclear Medicine Diagnostic Equipment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NUCLEAR MEDICINE DIAGNOSTIC EQUIPMENT BY GEOGRAPHIC REGION
4.1 World Historic Nuclear Medicine Diagnostic Equipment Market Size by Geographic Region (2021-2026)
4.1.1 Global Nuclear Medicine Diagnostic Equipment Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Nuclear Medicine Diagnostic Equipment Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Nuclear Medicine Diagnostic Equipment Market Size by Country/Region (2021-2026)
4.2.1 Global Nuclear Medicine Diagnostic Equipment Annual Sales by Country/Region (2021-2026)
4.2.2 Global Nuclear Medicine Diagnostic Equipment Annual Revenue by Country/Region (2021-2026)
4.3 Americas Nuclear Medicine Diagnostic Equipment Sales Growth
4.4 APAC Nuclear Medicine Diagnostic Equipment Sales Growth
4.5 Europe Nuclear Medicine Diagnostic Equipment Sales Growth
4.6 Middle East & Africa Nuclear Medicine Diagnostic Equipment Sales Growth
5 AMERICAS
5.1 Americas Nuclear Medicine Diagnostic Equipment Sales by Country
5.1.1 Americas Nuclear Medicine Diagnostic Equipment Sales by Country (2021-2026)
5.1.2 Americas Nuclear Medicine Diagnostic Equipment Revenue by Country (2021-2026)
5.2 Americas Nuclear Medicine Diagnostic Equipment Sales by Type (2021-2026)
5.3 Americas Nuclear Medicine Diagnostic Equipment Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nuclear Medicine Diagnostic Equipment Sales by Region
6.1.1 APAC Nuclear Medicine Diagnostic Equipment Sales by Region (2021-2026)
6.1.2 APAC Nuclear Medicine Diagnostic Equipment Revenue by Region (2021-2026)
6.2 APAC Nuclear Medicine Diagnostic Equipment Sales by Type (2021-2026)
6.3 APAC Nuclear Medicine Diagnostic Equipment Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Nuclear Medicine Diagnostic Equipment by Country
7.1.1 Europe Nuclear Medicine Diagnostic Equipment Sales by Country (2021-2026)
7.1.2 Europe Nuclear Medicine Diagnostic Equipment Revenue by Country (2021-2026)
7.2 Europe Nuclear Medicine Diagnostic Equipment Sales by Type (2021-2026)
7.3 Europe Nuclear Medicine Diagnostic Equipment Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nuclear Medicine Diagnostic Equipment by Country
8.1.1 Middle East & Africa Nuclear Medicine Diagnostic Equipment Sales by Country (2021-2026)
8.1.2 Middle East & Africa Nuclear Medicine Diagnostic Equipment Revenue by Country (2021-2026)
8.2 Middle East & Africa Nuclear Medicine Diagnostic Equipment Sales by Type (2021-2026)
8.3 Middle East & Africa Nuclear Medicine Diagnostic Equipment Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nuclear Medicine Diagnostic Equipment
10.3 Manufacturing Process Analysis of Nuclear Medicine Diagnostic Equipment
10.4 Industry Chain Structure of Nuclear Medicine Diagnostic Equipment
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nuclear Medicine Diagnostic Equipment Distributors
11.3 Nuclear Medicine Diagnostic Equipment Customer
12 WORLD FORECAST REVIEW FOR NUCLEAR MEDICINE DIAGNOSTIC EQUIPMENT BY GEOGRAPHIC REGION
12.1 Global Nuclear Medicine Diagnostic Equipment Market Size Forecast by Region
12.1.1 Global Nuclear Medicine Diagnostic Equipment Forecast by Region (2027-2032)
12.1.2 Global Nuclear Medicine Diagnostic Equipment Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Nuclear Medicine Diagnostic Equipment Forecast by Type (2027-2032)
12.7 Global Nuclear Medicine Diagnostic Equipment Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 GE HealthCare
13.1.1 GE HealthCare Company Information
13.1.2 GE HealthCare Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
13.1.3 GE HealthCare Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 GE HealthCare Main Business Overview
13.1.5 GE HealthCare Latest Developments
13.2 Siemens Healthineers
13.2.1 Siemens Healthineers Company Information
13.2.2 Siemens Healthineers Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
13.2.3 Siemens Healthineers Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Siemens Healthineers Main Business Overview
13.2.5 Siemens Healthineers Latest Developments
13.3 Philips
13.3.1 Philips Company Information
13.3.2 Philips Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
13.3.3 Philips Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Philips Main Business Overview
13.3.5 Philips Latest Developments
13.4 Mediso Medical Imaging Systems
13.4.1 Mediso Medical Imaging Systems Company Information
13.4.2 Mediso Medical Imaging Systems Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
13.4.3 Mediso Medical Imaging Systems Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Mediso Medical Imaging Systems Main Business Overview
13.4.5 Mediso Medical Imaging Systems Latest Developments
13.5 Digirad
13.5.1 Digirad Company Information
13.5.2 Digirad Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
13.5.3 Digirad Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Digirad Main Business Overview
13.5.5 Digirad Latest Developments
13.6 Toshiba
13.6.1 Toshiba Company Information
13.6.2 Toshiba Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
13.6.3 Toshiba Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Toshiba Main Business Overview
13.6.5 Toshiba Latest Developments
13.7 Compa??a Mexicana
13.7.1 Compa??a Mexicana Company Information
13.7.2 Compa??a Mexicana Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
13.7.3 Compa??a Mexicana Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Compa??a Mexicana Main Business Overview
13.7.5 Compa??a Mexicana Latest Developments
13.8 SurgicEye
13.8.1 SurgicEye Company Information
13.8.2 SurgicEye Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
13.8.3 SurgicEye Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 SurgicEye Main Business Overview
13.8.5 SurgicEye Latest Developments
13.9 CMR Naviscan
13.9.1 CMR Naviscan Company Information
13.9.2 CMR Naviscan Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
13.9.3 CMR Naviscan Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 CMR Naviscan Main Business Overview
13.9.5 CMR Naviscan Latest Developments
13.10 DDD-Diagnostic
13.10.1 DDD-Diagnostic Company Information
13.10.2 DDD-Diagnostic Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
13.10.3 DDD-Diagnostic Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 DDD-Diagnostic Main Business Overview
13.10.5 DDD-Diagnostic Latest Developments
13.11 Positron
13.11.1 Positron Company Information
13.11.2 Positron Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
13.11.3 Positron Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Positron Main Business Overview
13.11.5 Positron Latest Developments
13.12 TeraRecon
13.12.1 TeraRecon Company Information
13.12.2 TeraRecon Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
13.12.3 TeraRecon Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 TeraRecon Main Business Overview
13.12.5 TeraRecon Latest Developments
13.13 Neusoft Group
13.13.1 Neusoft Group Company Information
13.13.2 Neusoft Group Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
13.13.3 Neusoft Group Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Neusoft Group Main Business Overview
13.13.5 Neusoft Group Latest Developments
13.14 United Imaging
13.14.1 United Imaging Company Information
13.14.2 United Imaging Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
13.14.3 United Imaging Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 United Imaging Main Business Overview
13.14.5 United Imaging Latest Developments
13.15 MinFound Medical
13.15.1 MinFound Medical Company Information
13.15.2 MinFound Medical Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
13.15.3 MinFound Medical Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 MinFound Medical Main Business Overview
13.15.5 MinFound Medical Latest Developments
13.16 SinoUnion Healthcare
13.16.1 SinoUnion Healthcare Company Information
13.16.2 SinoUnion Healthcare Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
13.16.3 SinoUnion Healthcare Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 SinoUnion Healthcare Main Business Overview
13.16.5 SinoUnion Healthcare Latest Developments
13.17 Top Grade Healthcare
13.17.1 Top Grade Healthcare Company Information
13.17.2 Top Grade Healthcare Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
13.17.3 Top Grade Healthcare Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Top Grade Healthcare Main Business Overview
13.17.5 Top Grade Healthcare Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nuclear Medicine Diagnostic Equipment Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Nuclear Medicine Diagnostic Equipment by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Nuclear Medicine Diagnostic Equipment by Country/Region, 2021, 2025 & 2032
2.2 Nuclear Medicine Diagnostic Equipment Segment by Type
2.2.1 SPECT
2.2.2 PET
2.2.3 Nuclear Medicine Diagnostic Equipment Sales by Type
2.2.3.1 Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Type (2021-2026)
2.2.3.2 Global Nuclear Medicine Diagnostic Equipment Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Nuclear Medicine Diagnostic Equipment Sale Price by Type (2021-2026)
2.3 Nuclear Medicine Diagnostic Equipment Segment by Application
2.3.1 Tumor Imaging
2.3.2 Bone Marrow Imaging
2.3.3 Endocrine System Imaging
2.3.4 Urinary System Imaging
2.3.5 Others
2.3.6 Nuclear Medicine Diagnostic Equipment Sales by Application
2.3.6.1 Global Nuclear Medicine Diagnostic Equipment Sale Market Share by Application (2021-2026)
2.3.6.2 Global Nuclear Medicine Diagnostic Equipment Revenue and Market Share by Application (2021-2026)
2.3.6.3 Global Nuclear Medicine Diagnostic Equipment Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Nuclear Medicine Diagnostic Equipment Breakdown Data by Company
3.1.1 Global Nuclear Medicine Diagnostic Equipment Annual Sales by Company (2021-2026)
3.1.2 Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Company (2021-2026)
3.2 Global Nuclear Medicine Diagnostic Equipment Annual Revenue by Company (2021-2026)
3.2.1 Global Nuclear Medicine Diagnostic Equipment Revenue by Company (2021-2026)
3.2.2 Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Company (2021-2026)
3.3 Global Nuclear Medicine Diagnostic Equipment Sale Price by Company
3.4 Key Manufacturers Nuclear Medicine Diagnostic Equipment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nuclear Medicine Diagnostic Equipment Product Location Distribution
3.4.2 Players Nuclear Medicine Diagnostic Equipment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NUCLEAR MEDICINE DIAGNOSTIC EQUIPMENT BY GEOGRAPHIC REGION
4.1 World Historic Nuclear Medicine Diagnostic Equipment Market Size by Geographic Region (2021-2026)
4.1.1 Global Nuclear Medicine Diagnostic Equipment Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Nuclear Medicine Diagnostic Equipment Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Nuclear Medicine Diagnostic Equipment Market Size by Country/Region (2021-2026)
4.2.1 Global Nuclear Medicine Diagnostic Equipment Annual Sales by Country/Region (2021-2026)
4.2.2 Global Nuclear Medicine Diagnostic Equipment Annual Revenue by Country/Region (2021-2026)
4.3 Americas Nuclear Medicine Diagnostic Equipment Sales Growth
4.4 APAC Nuclear Medicine Diagnostic Equipment Sales Growth
4.5 Europe Nuclear Medicine Diagnostic Equipment Sales Growth
4.6 Middle East & Africa Nuclear Medicine Diagnostic Equipment Sales Growth
5 AMERICAS
5.1 Americas Nuclear Medicine Diagnostic Equipment Sales by Country
5.1.1 Americas Nuclear Medicine Diagnostic Equipment Sales by Country (2021-2026)
5.1.2 Americas Nuclear Medicine Diagnostic Equipment Revenue by Country (2021-2026)
5.2 Americas Nuclear Medicine Diagnostic Equipment Sales by Type (2021-2026)
5.3 Americas Nuclear Medicine Diagnostic Equipment Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nuclear Medicine Diagnostic Equipment Sales by Region
6.1.1 APAC Nuclear Medicine Diagnostic Equipment Sales by Region (2021-2026)
6.1.2 APAC Nuclear Medicine Diagnostic Equipment Revenue by Region (2021-2026)
6.2 APAC Nuclear Medicine Diagnostic Equipment Sales by Type (2021-2026)
6.3 APAC Nuclear Medicine Diagnostic Equipment Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Nuclear Medicine Diagnostic Equipment by Country
7.1.1 Europe Nuclear Medicine Diagnostic Equipment Sales by Country (2021-2026)
7.1.2 Europe Nuclear Medicine Diagnostic Equipment Revenue by Country (2021-2026)
7.2 Europe Nuclear Medicine Diagnostic Equipment Sales by Type (2021-2026)
7.3 Europe Nuclear Medicine Diagnostic Equipment Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nuclear Medicine Diagnostic Equipment by Country
8.1.1 Middle East & Africa Nuclear Medicine Diagnostic Equipment Sales by Country (2021-2026)
8.1.2 Middle East & Africa Nuclear Medicine Diagnostic Equipment Revenue by Country (2021-2026)
8.2 Middle East & Africa Nuclear Medicine Diagnostic Equipment Sales by Type (2021-2026)
8.3 Middle East & Africa Nuclear Medicine Diagnostic Equipment Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nuclear Medicine Diagnostic Equipment
10.3 Manufacturing Process Analysis of Nuclear Medicine Diagnostic Equipment
10.4 Industry Chain Structure of Nuclear Medicine Diagnostic Equipment
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nuclear Medicine Diagnostic Equipment Distributors
11.3 Nuclear Medicine Diagnostic Equipment Customer
12 WORLD FORECAST REVIEW FOR NUCLEAR MEDICINE DIAGNOSTIC EQUIPMENT BY GEOGRAPHIC REGION
12.1 Global Nuclear Medicine Diagnostic Equipment Market Size Forecast by Region
12.1.1 Global Nuclear Medicine Diagnostic Equipment Forecast by Region (2027-2032)
12.1.2 Global Nuclear Medicine Diagnostic Equipment Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Nuclear Medicine Diagnostic Equipment Forecast by Type (2027-2032)
12.7 Global Nuclear Medicine Diagnostic Equipment Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 GE HealthCare
13.1.1 GE HealthCare Company Information
13.1.2 GE HealthCare Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
13.1.3 GE HealthCare Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 GE HealthCare Main Business Overview
13.1.5 GE HealthCare Latest Developments
13.2 Siemens Healthineers
13.2.1 Siemens Healthineers Company Information
13.2.2 Siemens Healthineers Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
13.2.3 Siemens Healthineers Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Siemens Healthineers Main Business Overview
13.2.5 Siemens Healthineers Latest Developments
13.3 Philips
13.3.1 Philips Company Information
13.3.2 Philips Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
13.3.3 Philips Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Philips Main Business Overview
13.3.5 Philips Latest Developments
13.4 Mediso Medical Imaging Systems
13.4.1 Mediso Medical Imaging Systems Company Information
13.4.2 Mediso Medical Imaging Systems Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
13.4.3 Mediso Medical Imaging Systems Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Mediso Medical Imaging Systems Main Business Overview
13.4.5 Mediso Medical Imaging Systems Latest Developments
13.5 Digirad
13.5.1 Digirad Company Information
13.5.2 Digirad Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
13.5.3 Digirad Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Digirad Main Business Overview
13.5.5 Digirad Latest Developments
13.6 Toshiba
13.6.1 Toshiba Company Information
13.6.2 Toshiba Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
13.6.3 Toshiba Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Toshiba Main Business Overview
13.6.5 Toshiba Latest Developments
13.7 Compa??a Mexicana
13.7.1 Compa??a Mexicana Company Information
13.7.2 Compa??a Mexicana Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
13.7.3 Compa??a Mexicana Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Compa??a Mexicana Main Business Overview
13.7.5 Compa??a Mexicana Latest Developments
13.8 SurgicEye
13.8.1 SurgicEye Company Information
13.8.2 SurgicEye Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
13.8.3 SurgicEye Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 SurgicEye Main Business Overview
13.8.5 SurgicEye Latest Developments
13.9 CMR Naviscan
13.9.1 CMR Naviscan Company Information
13.9.2 CMR Naviscan Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
13.9.3 CMR Naviscan Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 CMR Naviscan Main Business Overview
13.9.5 CMR Naviscan Latest Developments
13.10 DDD-Diagnostic
13.10.1 DDD-Diagnostic Company Information
13.10.2 DDD-Diagnostic Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
13.10.3 DDD-Diagnostic Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 DDD-Diagnostic Main Business Overview
13.10.5 DDD-Diagnostic Latest Developments
13.11 Positron
13.11.1 Positron Company Information
13.11.2 Positron Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
13.11.3 Positron Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Positron Main Business Overview
13.11.5 Positron Latest Developments
13.12 TeraRecon
13.12.1 TeraRecon Company Information
13.12.2 TeraRecon Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
13.12.3 TeraRecon Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 TeraRecon Main Business Overview
13.12.5 TeraRecon Latest Developments
13.13 Neusoft Group
13.13.1 Neusoft Group Company Information
13.13.2 Neusoft Group Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
13.13.3 Neusoft Group Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Neusoft Group Main Business Overview
13.13.5 Neusoft Group Latest Developments
13.14 United Imaging
13.14.1 United Imaging Company Information
13.14.2 United Imaging Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
13.14.3 United Imaging Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 United Imaging Main Business Overview
13.14.5 United Imaging Latest Developments
13.15 MinFound Medical
13.15.1 MinFound Medical Company Information
13.15.2 MinFound Medical Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
13.15.3 MinFound Medical Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 MinFound Medical Main Business Overview
13.15.5 MinFound Medical Latest Developments
13.16 SinoUnion Healthcare
13.16.1 SinoUnion Healthcare Company Information
13.16.2 SinoUnion Healthcare Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
13.16.3 SinoUnion Healthcare Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 SinoUnion Healthcare Main Business Overview
13.16.5 SinoUnion Healthcare Latest Developments
13.17 Top Grade Healthcare
13.17.1 Top Grade Healthcare Company Information
13.17.2 Top Grade Healthcare Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
13.17.3 Top Grade Healthcare Nuclear Medicine Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Top Grade Healthcare Main Business Overview
13.17.5 Top Grade Healthcare Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Nuclear Medicine Diagnostic Equipment Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Nuclear Medicine Diagnostic Equipment Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of SPECT
Table 4. Major Players of PET
Table 5. Global Nuclear Medicine Diagnostic Equipment Sales by Type (2021-2026) & (K Units)
Table 6. Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Type (2021-2026)
Table 7. Global Nuclear Medicine Diagnostic Equipment Revenue by Type (2021-2026) & ($ million)
Table 8. Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Type (2021-2026)
Table 9. Global Nuclear Medicine Diagnostic Equipment Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Nuclear Medicine Diagnostic Equipment Sale by Application (2021-2026) & (K Units)
Table 11. Global Nuclear Medicine Diagnostic Equipment Sale Market Share by Application (2021-2026)
Table 12. Global Nuclear Medicine Diagnostic Equipment Revenue by Application (2021-2026) & ($ million)
Table 13. Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Application (2021-2026)
Table 14. Global Nuclear Medicine Diagnostic Equipment Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Nuclear Medicine Diagnostic Equipment Sales by Company (2021-2026) & (K Units)
Table 16. Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Company (2021-2026)
Table 17. Global Nuclear Medicine Diagnostic Equipment Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Company (2021-2026)
Table 19. Global Nuclear Medicine Diagnostic Equipment Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Nuclear Medicine Diagnostic Equipment Producing Area Distribution and Sales Area
Table 21. Players Nuclear Medicine Diagnostic Equipment Products Offered
Table 22. Nuclear Medicine Diagnostic Equipment Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Nuclear Medicine Diagnostic Equipment Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Nuclear Medicine Diagnostic Equipment Sales Market Share Geographic Region (2021-2026)
Table 27. Global Nuclear Medicine Diagnostic Equipment Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Nuclear Medicine Diagnostic Equipment Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Country/Region (2021-2026)
Table 31. Global Nuclear Medicine Diagnostic Equipment Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Nuclear Medicine Diagnostic Equipment Sales by Country (2021-2026) & (K Units)
Table 34. Americas Nuclear Medicine Diagnostic Equipment Sales Market Share by Country (2021-2026)
Table 35. Americas Nuclear Medicine Diagnostic Equipment Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Nuclear Medicine Diagnostic Equipment Sales by Type (2021-2026) & (K Units)
Table 37. Americas Nuclear Medicine Diagnostic Equipment Sales by Application (2021-2026) & (K Units)
Table 38. APAC Nuclear Medicine Diagnostic Equipment Sales by Region (2021-2026) & (K Units)
Table 39. APAC Nuclear Medicine Diagnostic Equipment Sales Market Share by Region (2021-2026)
Table 40. APAC Nuclear Medicine Diagnostic Equipment Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Nuclear Medicine Diagnostic Equipment Sales by Type (2021-2026) & (K Units)
Table 42. APAC Nuclear Medicine Diagnostic Equipment Sales by Application (2021-2026) & (K Units)
Table 43. Europe Nuclear Medicine Diagnostic Equipment Sales by Country (2021-2026) & (K Units)
Table 44. Europe Nuclear Medicine Diagnostic Equipment Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Nuclear Medicine Diagnostic Equipment Sales by Type (2021-2026) & (K Units)
Table 46. Europe Nuclear Medicine Diagnostic Equipment Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Nuclear Medicine Diagnostic Equipment Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Nuclear Medicine Diagnostic Equipment Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Nuclear Medicine Diagnostic Equipment Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Nuclear Medicine Diagnostic Equipment Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Nuclear Medicine Diagnostic Equipment
Table 52. Key Market Challenges & Risks of Nuclear Medicine Diagnostic Equipment
Table 53. Key Industry Trends of Nuclear Medicine Diagnostic Equipment
Table 54. Nuclear Medicine Diagnostic Equipment Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Nuclear Medicine Diagnostic Equipment Distributors List
Table 57. Nuclear Medicine Diagnostic Equipment Customer List
Table 58. Global Nuclear Medicine Diagnostic Equipment Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Nuclear Medicine Diagnostic Equipment Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Nuclear Medicine Diagnostic Equipment Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Nuclear Medicine Diagnostic Equipment Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Nuclear Medicine Diagnostic Equipment Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Nuclear Medicine Diagnostic Equipment Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Nuclear Medicine Diagnostic Equipment Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Nuclear Medicine Diagnostic Equipment Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Nuclear Medicine Diagnostic Equipment Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Nuclear Medicine Diagnostic Equipment Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Nuclear Medicine Diagnostic Equipment Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Nuclear Medicine Diagnostic Equipment Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Nuclear Medicine Diagnostic Equipment Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Nuclear Medicine Diagnostic Equipment Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. GE HealthCare Basic Information, Nuclear Medicine Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 73. GE HealthCare Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
Table 74. GE HealthCare Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. GE HealthCare Main Business
Table 76. GE HealthCare Latest Developments
Table 77. Siemens Healthineers Basic Information, Nuclear Medicine Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 78. Siemens Healthineers Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
Table 79. Siemens Healthineers Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Siemens Healthineers Main Business
Table 81. Siemens Healthineers Latest Developments
Table 82. Philips Basic Information, Nuclear Medicine Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 83. Philips Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
Table 84. Philips Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Philips Main Business
Table 86. Philips Latest Developments
Table 87. Mediso Medical Imaging Systems Basic Information, Nuclear Medicine Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 88. Mediso Medical Imaging Systems Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
Table 89. Mediso Medical Imaging Systems Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Mediso Medical Imaging Systems Main Business
Table 91. Mediso Medical Imaging Systems Latest Developments
Table 92. Digirad Basic Information, Nuclear Medicine Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 93. Digirad Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
Table 94. Digirad Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Digirad Main Business
Table 96. Digirad Latest Developments
Table 97. Toshiba Basic Information, Nuclear Medicine Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 98. Toshiba Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
Table 99. Toshiba Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Toshiba Main Business
Table 101. Toshiba Latest Developments
Table 102. Compa??a Mexicana Basic Information, Nuclear Medicine Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 103. Compa??a Mexicana Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
Table 104. Compa??a Mexicana Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Compa??a Mexicana Main Business
Table 106. Compa??a Mexicana Latest Developments
Table 107. SurgicEye Basic Information, Nuclear Medicine Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 108. SurgicEye Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
Table 109. SurgicEye Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. SurgicEye Main Business
Table 111. SurgicEye Latest Developments
Table 112. CMR Naviscan Basic Information, Nuclear Medicine Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 113. CMR Naviscan Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
Table 114. CMR Naviscan Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. CMR Naviscan Main Business
Table 116. CMR Naviscan Latest Developments
Table 117. DDD-Diagnostic Basic Information, Nuclear Medicine Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 118. DDD-Diagnostic Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
Table 119. DDD-Diagnostic Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. DDD-Diagnostic Main Business
Table 121. DDD-Diagnostic Latest Developments
Table 122. Positron Basic Information, Nuclear Medicine Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 123. Positron Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
Table 124. Positron Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Positron Main Business
Table 126. Positron Latest Developments
Table 127. TeraRecon Basic Information, Nuclear Medicine Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 128. TeraRecon Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
Table 129. TeraRecon Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. TeraRecon Main Business
Table 131. TeraRecon Latest Developments
Table 132. Neusoft Group Basic Information, Nuclear Medicine Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 133. Neusoft Group Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
Table 134. Neusoft Group Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Neusoft Group Main Business
Table 136. Neusoft Group Latest Developments
Table 137. United Imaging Basic Information, Nuclear Medicine Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 138. United Imaging Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
Table 139. United Imaging Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. United Imaging Main Business
Table 141. United Imaging Latest Developments
Table 142. MinFound Medical Basic Information, Nuclear Medicine Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 143. MinFound Medical Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
Table 144. MinFound Medical Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. MinFound Medical Main Business
Table 146. MinFound Medical Latest Developments
Table 147. SinoUnion Healthcare Basic Information, Nuclear Medicine Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 148. SinoUnion Healthcare Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
Table 149. SinoUnion Healthcare Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 150. SinoUnion Healthcare Main Business
Table 151. SinoUnion Healthcare Latest Developments
Table 152. Top Grade Healthcare Basic Information, Nuclear Medicine Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 153. Top Grade Healthcare Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
Table 154. Top Grade Healthcare Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 155. Top Grade Healthcare Main Business
Table 156. Top Grade Healthcare Latest Developments
Table 1. Nuclear Medicine Diagnostic Equipment Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Nuclear Medicine Diagnostic Equipment Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of SPECT
Table 4. Major Players of PET
Table 5. Global Nuclear Medicine Diagnostic Equipment Sales by Type (2021-2026) & (K Units)
Table 6. Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Type (2021-2026)
Table 7. Global Nuclear Medicine Diagnostic Equipment Revenue by Type (2021-2026) & ($ million)
Table 8. Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Type (2021-2026)
Table 9. Global Nuclear Medicine Diagnostic Equipment Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Nuclear Medicine Diagnostic Equipment Sale by Application (2021-2026) & (K Units)
Table 11. Global Nuclear Medicine Diagnostic Equipment Sale Market Share by Application (2021-2026)
Table 12. Global Nuclear Medicine Diagnostic Equipment Revenue by Application (2021-2026) & ($ million)
Table 13. Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Application (2021-2026)
Table 14. Global Nuclear Medicine Diagnostic Equipment Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Nuclear Medicine Diagnostic Equipment Sales by Company (2021-2026) & (K Units)
Table 16. Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Company (2021-2026)
Table 17. Global Nuclear Medicine Diagnostic Equipment Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Company (2021-2026)
Table 19. Global Nuclear Medicine Diagnostic Equipment Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Nuclear Medicine Diagnostic Equipment Producing Area Distribution and Sales Area
Table 21. Players Nuclear Medicine Diagnostic Equipment Products Offered
Table 22. Nuclear Medicine Diagnostic Equipment Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Nuclear Medicine Diagnostic Equipment Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Nuclear Medicine Diagnostic Equipment Sales Market Share Geographic Region (2021-2026)
Table 27. Global Nuclear Medicine Diagnostic Equipment Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Nuclear Medicine Diagnostic Equipment Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Country/Region (2021-2026)
Table 31. Global Nuclear Medicine Diagnostic Equipment Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Nuclear Medicine Diagnostic Equipment Sales by Country (2021-2026) & (K Units)
Table 34. Americas Nuclear Medicine Diagnostic Equipment Sales Market Share by Country (2021-2026)
Table 35. Americas Nuclear Medicine Diagnostic Equipment Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Nuclear Medicine Diagnostic Equipment Sales by Type (2021-2026) & (K Units)
Table 37. Americas Nuclear Medicine Diagnostic Equipment Sales by Application (2021-2026) & (K Units)
Table 38. APAC Nuclear Medicine Diagnostic Equipment Sales by Region (2021-2026) & (K Units)
Table 39. APAC Nuclear Medicine Diagnostic Equipment Sales Market Share by Region (2021-2026)
Table 40. APAC Nuclear Medicine Diagnostic Equipment Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Nuclear Medicine Diagnostic Equipment Sales by Type (2021-2026) & (K Units)
Table 42. APAC Nuclear Medicine Diagnostic Equipment Sales by Application (2021-2026) & (K Units)
Table 43. Europe Nuclear Medicine Diagnostic Equipment Sales by Country (2021-2026) & (K Units)
Table 44. Europe Nuclear Medicine Diagnostic Equipment Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Nuclear Medicine Diagnostic Equipment Sales by Type (2021-2026) & (K Units)
Table 46. Europe Nuclear Medicine Diagnostic Equipment Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Nuclear Medicine Diagnostic Equipment Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Nuclear Medicine Diagnostic Equipment Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Nuclear Medicine Diagnostic Equipment Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Nuclear Medicine Diagnostic Equipment Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Nuclear Medicine Diagnostic Equipment
Table 52. Key Market Challenges & Risks of Nuclear Medicine Diagnostic Equipment
Table 53. Key Industry Trends of Nuclear Medicine Diagnostic Equipment
Table 54. Nuclear Medicine Diagnostic Equipment Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Nuclear Medicine Diagnostic Equipment Distributors List
Table 57. Nuclear Medicine Diagnostic Equipment Customer List
Table 58. Global Nuclear Medicine Diagnostic Equipment Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Nuclear Medicine Diagnostic Equipment Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Nuclear Medicine Diagnostic Equipment Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Nuclear Medicine Diagnostic Equipment Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Nuclear Medicine Diagnostic Equipment Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Nuclear Medicine Diagnostic Equipment Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Nuclear Medicine Diagnostic Equipment Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Nuclear Medicine Diagnostic Equipment Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Nuclear Medicine Diagnostic Equipment Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Nuclear Medicine Diagnostic Equipment Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Nuclear Medicine Diagnostic Equipment Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Nuclear Medicine Diagnostic Equipment Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Nuclear Medicine Diagnostic Equipment Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Nuclear Medicine Diagnostic Equipment Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. GE HealthCare Basic Information, Nuclear Medicine Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 73. GE HealthCare Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
Table 74. GE HealthCare Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. GE HealthCare Main Business
Table 76. GE HealthCare Latest Developments
Table 77. Siemens Healthineers Basic Information, Nuclear Medicine Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 78. Siemens Healthineers Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
Table 79. Siemens Healthineers Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Siemens Healthineers Main Business
Table 81. Siemens Healthineers Latest Developments
Table 82. Philips Basic Information, Nuclear Medicine Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 83. Philips Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
Table 84. Philips Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Philips Main Business
Table 86. Philips Latest Developments
Table 87. Mediso Medical Imaging Systems Basic Information, Nuclear Medicine Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 88. Mediso Medical Imaging Systems Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
Table 89. Mediso Medical Imaging Systems Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Mediso Medical Imaging Systems Main Business
Table 91. Mediso Medical Imaging Systems Latest Developments
Table 92. Digirad Basic Information, Nuclear Medicine Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 93. Digirad Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
Table 94. Digirad Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Digirad Main Business
Table 96. Digirad Latest Developments
Table 97. Toshiba Basic Information, Nuclear Medicine Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 98. Toshiba Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
Table 99. Toshiba Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Toshiba Main Business
Table 101. Toshiba Latest Developments
Table 102. Compa??a Mexicana Basic Information, Nuclear Medicine Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 103. Compa??a Mexicana Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
Table 104. Compa??a Mexicana Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Compa??a Mexicana Main Business
Table 106. Compa??a Mexicana Latest Developments
Table 107. SurgicEye Basic Information, Nuclear Medicine Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 108. SurgicEye Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
Table 109. SurgicEye Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. SurgicEye Main Business
Table 111. SurgicEye Latest Developments
Table 112. CMR Naviscan Basic Information, Nuclear Medicine Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 113. CMR Naviscan Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
Table 114. CMR Naviscan Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. CMR Naviscan Main Business
Table 116. CMR Naviscan Latest Developments
Table 117. DDD-Diagnostic Basic Information, Nuclear Medicine Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 118. DDD-Diagnostic Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
Table 119. DDD-Diagnostic Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. DDD-Diagnostic Main Business
Table 121. DDD-Diagnostic Latest Developments
Table 122. Positron Basic Information, Nuclear Medicine Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 123. Positron Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
Table 124. Positron Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Positron Main Business
Table 126. Positron Latest Developments
Table 127. TeraRecon Basic Information, Nuclear Medicine Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 128. TeraRecon Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
Table 129. TeraRecon Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. TeraRecon Main Business
Table 131. TeraRecon Latest Developments
Table 132. Neusoft Group Basic Information, Nuclear Medicine Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 133. Neusoft Group Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
Table 134. Neusoft Group Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Neusoft Group Main Business
Table 136. Neusoft Group Latest Developments
Table 137. United Imaging Basic Information, Nuclear Medicine Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 138. United Imaging Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
Table 139. United Imaging Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. United Imaging Main Business
Table 141. United Imaging Latest Developments
Table 142. MinFound Medical Basic Information, Nuclear Medicine Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 143. MinFound Medical Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
Table 144. MinFound Medical Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. MinFound Medical Main Business
Table 146. MinFound Medical Latest Developments
Table 147. SinoUnion Healthcare Basic Information, Nuclear Medicine Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 148. SinoUnion Healthcare Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
Table 149. SinoUnion Healthcare Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 150. SinoUnion Healthcare Main Business
Table 151. SinoUnion Healthcare Latest Developments
Table 152. Top Grade Healthcare Basic Information, Nuclear Medicine Diagnostic Equipment Manufacturing Base, Sales Area and Its Competitors
Table 153. Top Grade Healthcare Nuclear Medicine Diagnostic Equipment Product Portfolios and Specifications
Table 154. Top Grade Healthcare Nuclear Medicine Diagnostic Equipment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 155. Top Grade Healthcare Main Business
Table 156. Top Grade Healthcare Latest Developments
LIST OF FIGURES
Figure 1. Picture of Nuclear Medicine Diagnostic Equipment
Figure 2. Nuclear Medicine Diagnostic Equipment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nuclear Medicine Diagnostic Equipment Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Nuclear Medicine Diagnostic Equipment Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Nuclear Medicine Diagnostic Equipment Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Nuclear Medicine Diagnostic Equipment Sales Market Share by Country/Region (2025)
Figure 10. Nuclear Medicine Diagnostic Equipment Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of SPECT
Figure 12. Product Picture of PET
Figure 13. Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Type in 2026
Figure 14. Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Type (2021-2026)
Figure 15. Nuclear Medicine Diagnostic Equipment Consumed in Tumor Imaging
Figure 16. Global Nuclear Medicine Diagnostic Equipment Market: Tumor Imaging (2021-2026) & (K Units)
Figure 17. Nuclear Medicine Diagnostic Equipment Consumed in Bone Marrow Imaging
Figure 18. Global Nuclear Medicine Diagnostic Equipment Market: Bone Marrow Imaging (2021-2026) & (K Units)
Figure 19. Nuclear Medicine Diagnostic Equipment Consumed in Endocrine System Imaging
Figure 20. Global Nuclear Medicine Diagnostic Equipment Market: Endocrine System Imaging (2021-2026) & (K Units)
Figure 21. Nuclear Medicine Diagnostic Equipment Consumed in Urinary System Imaging
Figure 22. Global Nuclear Medicine Diagnostic Equipment Market: Urinary System Imaging (2021-2026) & (K Units)
Figure 23. Nuclear Medicine Diagnostic Equipment Consumed in Others
Figure 24. Global Nuclear Medicine Diagnostic Equipment Market: Others (2021-2026) & (K Units)
Figure 25. Global Nuclear Medicine Diagnostic Equipment Sale Market Share by Application (2025)
Figure 26. Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Application in 2026
Figure 27. Nuclear Medicine Diagnostic Equipment Sales by Company in 2026 (K Units)
Figure 28. Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Company in 2026
Figure 29. Nuclear Medicine Diagnostic Equipment Revenue by Company in 2026 ($ millions)
Figure 30. Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Company in 2026
Figure 31. Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Geographic Region (2021-2026)
Figure 32. Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Geographic Region in 2026
Figure 33. Americas Nuclear Medicine Diagnostic Equipment Sales 2021-2026 (K Units)
Figure 34. Americas Nuclear Medicine Diagnostic Equipment Revenue 2021-2026 ($ millions)
Figure 35. APAC Nuclear Medicine Diagnostic Equipment Sales 2021-2026 (K Units)
Figure 36. APAC Nuclear Medicine Diagnostic Equipment Revenue 2021-2026 ($ millions)
Figure 37. Europe Nuclear Medicine Diagnostic Equipment Sales 2021-2026 (K Units)
Figure 38. Europe Nuclear Medicine Diagnostic Equipment Revenue 2021-2026 ($ millions)
Figure 39. Middle East & Africa Nuclear Medicine Diagnostic Equipment Sales 2021-2026 (K Units)
Figure 40. Middle East & Africa Nuclear Medicine Diagnostic Equipment Revenue 2021-2026 ($ millions)
Figure 41. Americas Nuclear Medicine Diagnostic Equipment Sales Market Share by Country in 2026
Figure 42. Americas Nuclear Medicine Diagnostic Equipment Revenue Market Share by Country (2021-2026)
Figure 43. Americas Nuclear Medicine Diagnostic Equipment Sales Market Share by Type (2021-2026)
Figure 44. Americas Nuclear Medicine Diagnostic Equipment Sales Market Share by Application (2021-2026)
Figure 45. United States Nuclear Medicine Diagnostic Equipment Revenue Growth 2021-2026 ($ millions)
Figure 46. Canada Nuclear Medicine Diagnostic Equipment Revenue Growth 2021-2026 ($ millions)
Figure 47. Mexico Nuclear Medicine Diagnostic Equipment Revenue Growth 2021-2026 ($ millions)
Figure 48. Brazil Nuclear Medicine Diagnostic Equipment Revenue Growth 2021-2026 ($ millions)
Figure 49. APAC Nuclear Medicine Diagnostic Equipment Sales Market Share by Region in 2026
Figure 50. APAC Nuclear Medicine Diagnostic Equipment Revenue Market Share by Region (2021-2026)
Figure 51. APAC Nuclear Medicine Diagnostic Equipment Sales Market Share by Type (2021-2026)
Figure 52. APAC Nuclear Medicine Diagnostic Equipment Sales Market Share by Application (2021-2026)
Figure 53. China Nuclear Medicine Diagnostic Equipment Revenue Growth 2021-2026 ($ millions)
Figure 54. Japan Nuclear Medicine Diagnostic Equipment Revenue Growth 2021-2026 ($ millions)
Figure 55. South Korea Nuclear Medicine Diagnostic Equipment Revenue Growth 2021-2026 ($ millions)
Figure 56. Southeast Asia Nuclear Medicine Diagnostic Equipment Revenue Growth 2021-2026 ($ millions)
Figure 57. India Nuclear Medicine Diagnostic Equipment Revenue Growth 2021-2026 ($ millions)
Figure 58. Australia Nuclear Medicine Diagnostic Equipment Revenue Growth 2021-2026 ($ millions)
Figure 59. China Taiwan Nuclear Medicine Diagnostic Equipment Revenue Growth 2021-2026 ($ millions)
Figure 60. Europe Nuclear Medicine Diagnostic Equipment Sales Market Share by Country in 2026
Figure 61. Europe Nuclear Medicine Diagnostic Equipment Revenue Market Share by Country (2021-2026)
Figure 62. Europe Nuclear Medicine Diagnostic Equipment Sales Market Share by Type (2021-2026)
Figure 63. Europe Nuclear Medicine Diagnostic Equipment Sales Market Share by Application (2021-2026)
Figure 64. Germany Nuclear Medicine Diagnostic Equipment Revenue Growth 2021-2026 ($ millions)
Figure 65. France Nuclear Medicine Diagnostic Equipment Revenue Growth 2021-2026 ($ millions)
Figure 66. UK Nuclear Medicine Diagnostic Equipment Revenue Growth 2021-2026 ($ millions)
Figure 67. Italy Nuclear Medicine Diagnostic Equipment Revenue Growth 2021-2026 ($ millions)
Figure 68. Russia Nuclear Medicine Diagnostic Equipment Revenue Growth 2021-2026 ($ millions)
Figure 69. Middle East & Africa Nuclear Medicine Diagnostic Equipment Sales Market Share by Country (2021-2026)
Figure 70. Middle East & Africa Nuclear Medicine Diagnostic Equipment Sales Market Share by Type (2021-2026)
Figure 71. Middle East & Africa Nuclear Medicine Diagnostic Equipment Sales Market Share by Application (2021-2026)
Figure 72. Egypt Nuclear Medicine Diagnostic Equipment Revenue Growth 2021-2026 ($ millions)
Figure 73. South Africa Nuclear Medicine Diagnostic Equipment Revenue Growth 2021-2026 ($ millions)
Figure 74. Israel Nuclear Medicine Diagnostic Equipment Revenue Growth 2021-2026 ($ millions)
Figure 75. Turkey Nuclear Medicine Diagnostic Equipment Revenue Growth 2021-2026 ($ millions)
Figure 76. GCC Countries Nuclear Medicine Diagnostic Equipment Revenue Growth 2021-2026 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Nuclear Medicine Diagnostic Equipment in 2026
Figure 78. Manufacturing Process Analysis of Nuclear Medicine Diagnostic Equipment
Figure 79. Industry Chain Structure of Nuclear Medicine Diagnostic Equipment
Figure 80. Channels of Distribution
Figure 81. Global Nuclear Medicine Diagnostic Equipment Sales Market Forecast by Region (2027-2032)
Figure 82. Global Nuclear Medicine Diagnostic Equipment Revenue Market Share Forecast by Region (2027-2032)
Figure 83. Global Nuclear Medicine Diagnostic Equipment Sales Market Share Forecast by Type (2027-2032)
Figure 84. Global Nuclear Medicine Diagnostic Equipment Revenue Market Share Forecast by Type (2027-2032)
Figure 85. Global Nuclear Medicine Diagnostic Equipment Sales Market Share Forecast by Application (2027-2032)
Figure 86. Global Nuclear Medicine Diagnostic Equipment Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Nuclear Medicine Diagnostic Equipment
Figure 2. Nuclear Medicine Diagnostic Equipment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nuclear Medicine Diagnostic Equipment Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Nuclear Medicine Diagnostic Equipment Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Nuclear Medicine Diagnostic Equipment Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Nuclear Medicine Diagnostic Equipment Sales Market Share by Country/Region (2025)
Figure 10. Nuclear Medicine Diagnostic Equipment Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of SPECT
Figure 12. Product Picture of PET
Figure 13. Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Type in 2026
Figure 14. Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Type (2021-2026)
Figure 15. Nuclear Medicine Diagnostic Equipment Consumed in Tumor Imaging
Figure 16. Global Nuclear Medicine Diagnostic Equipment Market: Tumor Imaging (2021-2026) & (K Units)
Figure 17. Nuclear Medicine Diagnostic Equipment Consumed in Bone Marrow Imaging
Figure 18. Global Nuclear Medicine Diagnostic Equipment Market: Bone Marrow Imaging (2021-2026) & (K Units)
Figure 19. Nuclear Medicine Diagnostic Equipment Consumed in Endocrine System Imaging
Figure 20. Global Nuclear Medicine Diagnostic Equipment Market: Endocrine System Imaging (2021-2026) & (K Units)
Figure 21. Nuclear Medicine Diagnostic Equipment Consumed in Urinary System Imaging
Figure 22. Global Nuclear Medicine Diagnostic Equipment Market: Urinary System Imaging (2021-2026) & (K Units)
Figure 23. Nuclear Medicine Diagnostic Equipment Consumed in Others
Figure 24. Global Nuclear Medicine Diagnostic Equipment Market: Others (2021-2026) & (K Units)
Figure 25. Global Nuclear Medicine Diagnostic Equipment Sale Market Share by Application (2025)
Figure 26. Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Application in 2026
Figure 27. Nuclear Medicine Diagnostic Equipment Sales by Company in 2026 (K Units)
Figure 28. Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Company in 2026
Figure 29. Nuclear Medicine Diagnostic Equipment Revenue by Company in 2026 ($ millions)
Figure 30. Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Company in 2026
Figure 31. Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Geographic Region (2021-2026)
Figure 32. Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Geographic Region in 2026
Figure 33. Americas Nuclear Medicine Diagnostic Equipment Sales 2021-2026 (K Units)
Figure 34. Americas Nuclear Medicine Diagnostic Equipment Revenue 2021-2026 ($ millions)
Figure 35. APAC Nuclear Medicine Diagnostic Equipment Sales 2021-2026 (K Units)
Figure 36. APAC Nuclear Medicine Diagnostic Equipment Revenue 2021-2026 ($ millions)
Figure 37. Europe Nuclear Medicine Diagnostic Equipment Sales 2021-2026 (K Units)
Figure 38. Europe Nuclear Medicine Diagnostic Equipment Revenue 2021-2026 ($ millions)
Figure 39. Middle East & Africa Nuclear Medicine Diagnostic Equipment Sales 2021-2026 (K Units)
Figure 40. Middle East & Africa Nuclear Medicine Diagnostic Equipment Revenue 2021-2026 ($ millions)
Figure 41. Americas Nuclear Medicine Diagnostic Equipment Sales Market Share by Country in 2026
Figure 42. Americas Nuclear Medicine Diagnostic Equipment Revenue Market Share by Country (2021-2026)
Figure 43. Americas Nuclear Medicine Diagnostic Equipment Sales Market Share by Type (2021-2026)
Figure 44. Americas Nuclear Medicine Diagnostic Equipment Sales Market Share by Application (2021-2026)
Figure 45. United States Nuclear Medicine Diagnostic Equipment Revenue Growth 2021-2026 ($ millions)
Figure 46. Canada Nuclear Medicine Diagnostic Equipment Revenue Growth 2021-2026 ($ millions)
Figure 47. Mexico Nuclear Medicine Diagnostic Equipment Revenue Growth 2021-2026 ($ millions)
Figure 48. Brazil Nuclear Medicine Diagnostic Equipment Revenue Growth 2021-2026 ($ millions)
Figure 49. APAC Nuclear Medicine Diagnostic Equipment Sales Market Share by Region in 2026
Figure 50. APAC Nuclear Medicine Diagnostic Equipment Revenue Market Share by Region (2021-2026)
Figure 51. APAC Nuclear Medicine Diagnostic Equipment Sales Market Share by Type (2021-2026)
Figure 52. APAC Nuclear Medicine Diagnostic Equipment Sales Market Share by Application (2021-2026)
Figure 53. China Nuclear Medicine Diagnostic Equipment Revenue Growth 2021-2026 ($ millions)
Figure 54. Japan Nuclear Medicine Diagnostic Equipment Revenue Growth 2021-2026 ($ millions)
Figure 55. South Korea Nuclear Medicine Diagnostic Equipment Revenue Growth 2021-2026 ($ millions)
Figure 56. Southeast Asia Nuclear Medicine Diagnostic Equipment Revenue Growth 2021-2026 ($ millions)
Figure 57. India Nuclear Medicine Diagnostic Equipment Revenue Growth 2021-2026 ($ millions)
Figure 58. Australia Nuclear Medicine Diagnostic Equipment Revenue Growth 2021-2026 ($ millions)
Figure 59. China Taiwan Nuclear Medicine Diagnostic Equipment Revenue Growth 2021-2026 ($ millions)
Figure 60. Europe Nuclear Medicine Diagnostic Equipment Sales Market Share by Country in 2026
Figure 61. Europe Nuclear Medicine Diagnostic Equipment Revenue Market Share by Country (2021-2026)
Figure 62. Europe Nuclear Medicine Diagnostic Equipment Sales Market Share by Type (2021-2026)
Figure 63. Europe Nuclear Medicine Diagnostic Equipment Sales Market Share by Application (2021-2026)
Figure 64. Germany Nuclear Medicine Diagnostic Equipment Revenue Growth 2021-2026 ($ millions)
Figure 65. France Nuclear Medicine Diagnostic Equipment Revenue Growth 2021-2026 ($ millions)
Figure 66. UK Nuclear Medicine Diagnostic Equipment Revenue Growth 2021-2026 ($ millions)
Figure 67. Italy Nuclear Medicine Diagnostic Equipment Revenue Growth 2021-2026 ($ millions)
Figure 68. Russia Nuclear Medicine Diagnostic Equipment Revenue Growth 2021-2026 ($ millions)
Figure 69. Middle East & Africa Nuclear Medicine Diagnostic Equipment Sales Market Share by Country (2021-2026)
Figure 70. Middle East & Africa Nuclear Medicine Diagnostic Equipment Sales Market Share by Type (2021-2026)
Figure 71. Middle East & Africa Nuclear Medicine Diagnostic Equipment Sales Market Share by Application (2021-2026)
Figure 72. Egypt Nuclear Medicine Diagnostic Equipment Revenue Growth 2021-2026 ($ millions)
Figure 73. South Africa Nuclear Medicine Diagnostic Equipment Revenue Growth 2021-2026 ($ millions)
Figure 74. Israel Nuclear Medicine Diagnostic Equipment Revenue Growth 2021-2026 ($ millions)
Figure 75. Turkey Nuclear Medicine Diagnostic Equipment Revenue Growth 2021-2026 ($ millions)
Figure 76. GCC Countries Nuclear Medicine Diagnostic Equipment Revenue Growth 2021-2026 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Nuclear Medicine Diagnostic Equipment in 2026
Figure 78. Manufacturing Process Analysis of Nuclear Medicine Diagnostic Equipment
Figure 79. Industry Chain Structure of Nuclear Medicine Diagnostic Equipment
Figure 80. Channels of Distribution
Figure 81. Global Nuclear Medicine Diagnostic Equipment Sales Market Forecast by Region (2027-2032)
Figure 82. Global Nuclear Medicine Diagnostic Equipment Revenue Market Share Forecast by Region (2027-2032)
Figure 83. Global Nuclear Medicine Diagnostic Equipment Sales Market Share Forecast by Type (2027-2032)
Figure 84. Global Nuclear Medicine Diagnostic Equipment Revenue Market Share Forecast by Type (2027-2032)
Figure 85. Global Nuclear Medicine Diagnostic Equipment Sales Market Share Forecast by Application (2027-2032)
Figure 86. Global Nuclear Medicine Diagnostic Equipment Revenue Market Share Forecast by Application (2027-2032)
